The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Intestinal barrier in inflammatory bowel disease
Open accessAbstract
A complex mucosal barrier protects as the first line of defense the surface of the healthy intestinal tract from adhesion and invasion by luminal microorganisms. In this review, we provide an overview about the major components of this protective system as for example an intact epithelium, the synthesis of various antimicrobial peptides (AMPs) and the formation of the mucus layer. We highlight the crucial importance of their correct functioning for the maintenance of a proper intestinal function and the prevention of dysbiosis and disease. Barrier disturbances including a defective production of AMPs, alterations in thickness or composition of the intestinal mucus layer, alterations of pattern-recognition receptors, defects in the process of autophagy as well as unresolved endoplasmic reticulum stress result in an inadequate host protection and are thought to play a crucial role in the pathogenesis of the inflammatory bowel diseases Crohn's disease and ulcerative colitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., & Flavell, R. A. (2005) · Science · doi:10.1126/science.1104911 · Cited by 1,776
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.-L., Barnich, N., Bringer, M.-A., Swidsinski, A., Beaugerie, L., & Colombel, J.-F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.061 · Cited by 1,566
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
Cadwell, K., Liu, J. Y., Brown, S. L., Miyoshi, H., Loh, J., Lennerz, J. K., Kishi, C., Kc, W., Carrero, J. A., Hunt, S., et al. (2008) · Nature · doi:10.1038/nature07416 · Cited by 1,542
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Johansson, M. E. V., Larsson, J. M. H., & Hansson, G. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006451107 · Cited by 1,452
Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
Kim, Y. S., & Ho, S. B. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0131-2 · Cited by 1,435
Mucin dynamics and enteric pathogens
McGuckin, M. A., Lindén, S. K., Sutton, P., & Florin, T. H. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2538 · Cited by 1,428
Vaishnava, S., Yamamoto, M., Severson, K. M., Ruhn, K. A., Yu, X., Koren, O., Ley, R., Wakeland, E. K., & Hooper, L. V. (2011) · Science · doi:10.1126/science.1209791 · Cited by 1,412
Kaser, A., Lee, A.-H., Franke, A., Glickman, J. N., Zeissig, S., Tilg, H., Nieuwenhuis, E. E. S., Higgins, D. E., Schreiber, S., Glimcher, L. H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.021 · Cited by 1,411
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
Travassos, L. H., Carneiro, L. A. M., Ramjeet, M., Hussey, S., Kim, Y.-G., Magalhães, J. G., Yuan, L., Soares, F., Chea, E., Le Bourhis, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1823 · Cited by 1,306
Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
Bevins, C. L., & Salzman, N. H. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2546 · Cited by 1,238
HELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Zeissig, S., Bürgel, N., Günzel, D., Richter, J., Mankertz, J., Wahnschaffe, U., Kroesen, A. J., Zeitz, M., Fromm, M., & Schulzke, J.-D. (2007) · Gut · doi:10.1136/gut.2006.094375 · Cited by 1,223
the Wellcome Trust Case Control Consortium, Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. R., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,155
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Canonical Wnt signals are essential for homeostasis of the intestinal epithelium
Pinto, D., Gregorieff, A., Begthel, H., & Clevers, H. (2003) · Genes & Development · doi:10.1101/gad.267103 · Cited by 1,026
Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., & Kanneganti, T.-D. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.003 · Cited by 989
Reduced Paneth cell α-defensins in ileal Crohn's disease
Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505256102 · Cited by 988
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Bauer, C., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., Tschopp, J., Endres, S., Latz, E., & Schnurr, M. (2010) · Gut · doi:10.1136/gut.2009.197822 · Cited by 906
D'Haens, G. R., Geboes, K., Peeters, M., Baert, F., Penninckx, F., & Rutgeerts, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70476-7 · Cited by 868
Rath, H. C., Herfarth, H. H., Ikeda, J. S., Grenther, W. B., Hamm, T. E., Balish, E., Taurog, J. D., Hammer, R. E., Wilson, K. H., & Sartor, R. B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118878 · Cited by 834
HOLLANDER, D., VADHEIM, C. M., BRETTHOLZ, E., PETERSEN, G. M., DELAHUNTY, T., & ROTTER, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 760
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
Rutgeerts, P., Peeters, M., Hiele, M., Vantrappen, G., Pennincx, F., Aerts, R., Kerremans, R., & Goboes, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90663-a · Cited by 759
Heazlewood, C. K., Cook, M. C., Eri, R., Price, G. R., Tauro, S. B., Taupin, D., Thornton, D. J., Png, C. W., Crockford, T. L., Cornall, R. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050054 · Cited by 701
Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor
Mashimo, H., Wu, D.-C., Podolsky, D. K., & Fishman, M. C. (1996) · Science · doi:10.1126/science.274.5285.262 · Cited by 701
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease
McCarroll, S. A., Huett, A., Kuballa, P., Chilewski, S. D., Landry, A., Goyette, P., Zody, M. C., Hall, J. L., Brant, S. R., Cho, J. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.215 · Cited by 655
Wnt/β-Catenin Is Essential for Intestinal Homeostasis and Maintenance of Intestinal Stem Cells
Fevr, T., Robine, S., Louvard, D., & Huelsken, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01034-07 · Cited by 649
Intestinal barrier dysfunction in inflammatory bowel diseases
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J., & Radford-Smith, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20539 · Cited by 627
Intestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626
Importance of disrupted intestinal barrier in inflammatory bowel diseases
Salim, S. Y., & Söderholm, J. D. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21403 · Cited by 602
Franchimont, D., Vermeire, S., El Housni, H., Pierik, M., Van Steen, K., Gustot, T., Quertinmont, E., Abramowicz, M., Van Gossum, A., Devière, J., et al. (2004) · Gut · doi:10.1136/gut.2003.030205 · Cited by 597
Barnich, N., Carvalho, F. A., Glasser, A.-L., Darcha, C., Jantscheff, P., Allez, M., Peeters, H., Bommelaer, G., Desreumaux, P., Colombel, J.-F., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30504 · Cited by 589
Production of β-defensins by human airway epithelia
Singh, P. K., Jia, H. P., Wiles, K., Hesselberth, J., Liu, L., Conway, B.-A. D., Greenberg, E. P., Valore, E. V., Welsh, M. J., Ganz, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14961 · Cited by 579
Epithelial crosstalk at the microbiota–mucosal interface
Wells, J. M., Rossi, O., Meijerink, M., & van Baarlen, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000092107 · Cited by 579
Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., & Salcedo, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0325z.x · Cited by 578
Nod2 is required for the regulation of commensal microbiota in the intestine
Petnicki-Ocwieja, T., Hrncir, T., Liu, Y.-J., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H., & Kobayashi, K. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907722106 · Cited by 564
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
Villani, A.-C., Lemire, M., Fortin, G., Louis, E., Silverberg, M. S., Collette, C., Baba, N., Libioulle, C., Belaiche, J., Bitton, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.285 · Cited by 525
Wnt5a Potentiates TGF-β Signaling to Promote Colonic Crypt Regeneration After Tissue Injury
Miyoshi, H., Ajima, R., Luo, C. T., Yamaguchi, T. P., & Stappenbeck, T. S. (2012) · Science · doi:10.1126/science.1223821 · Cited by 475
Role of mucus layers in gut infection and inflammation
Hansson, G. C. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.11.002 · Cited by 473
Defensins in innate antiviral immunity
Klotman, M. E., & Chang, T. L. (2006) · Nature Reviews Immunology · doi:10.1038/nri1860 · Cited by 471
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.
Pullan, R. D., Thomas, G. A., Rhodes, M., Newcombe, R. G., Williams, G. T., Allen, A., & Rhodes, J. (1994) · Gut · doi:10.1136/gut.35.3.353 · Cited by 467
Kallikrein‐mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin
Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R. A., Schechter, N. M., Bonnart, C., Descargues, P., Hovnanian, A., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-6075com · Cited by 462
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1
Schroeder, B. O., Wu, Z., Nuding, S., Groscurth, S., Marcinowski, M., Beisner, J., Buchner, J., Schaller, M., Stange, E. F., & Wehkamp, J. (2011) · Nature · doi:10.1038/nature09674 · Cited by 457
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
Hirota, S. A., Ng, J., Lueng, A., Khajah, M., Parhar, K., Li, Y., Lam, V., Potentier, M. S., Ng, K., Bawa, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21478 · Cited by 431
The protein disulfide isomerase AGR2 is essential for production of intestinal mucus
Park, S.-W., Zhen, G., Verhaeghe, C., Nakagami, Y., Nguyenvu, L. T., Barczak, A. J., Killeen, N., & Erle, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808722106 · Cited by 417
Increased sensitivity to dextran sodium sulfate colitis in IRE1β-deficient mice
Bertolotti, A., Wang, X., Novoa, I., Jungreis, R., Schlessinger, K., Cho, J. H., West, A. B., & Ron, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11476 · Cited by 410
Epithelial Tight Junctions in Intestinal Inflammation
Schulzke, J. D., Ploeger, S., Amasheh, M., Fromm, A., Zeissig, S., Troeger, H., Richter, J., Bojarski, C., Schumann, M., & Fromm, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04062.x · Cited by 399
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease
Conte, M. P., Schippa, S., Zamboni, I., Penta, M., Chiarini, F., Seganti, L., Osborn, J., Falconieri, P., Borrelli, O., & Cucchiara, S. (2006) · Gut · doi:10.1136/gut.2005.078824 · Cited by 383
Buhner, S., Buning, C., Genschel, J., Kling, K., Herrmann, D., Dignass, A., Kuechler, I., Krueger, S., Schmidt, H. H.-J., & Lochs, H. (2006) · Gut · doi:10.1136/gut.2005.065557 · Cited by 368
Larsson, J. M. H., Karlsson, H., Crespo, J. G., Johansson, M. E. V., Eklund, L., Sjövall, H., & Hansson, G. C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21625 · Cited by 360
BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2
Cario, E. (2005) · Gut · doi:10.1136/gut.2004.062794 · Cited by 351
Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls
Kleessen, B., Kroesen, A. J., Buhr, H. J., & Blaut, M. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320378220 · Cited by 351
Role of Intestinal Mucins in Innate Host Defense Mechanisms against Pathogens
Dharmani, P., Srivastava, V., Kissoon-Singh, V., & Chadee, K. (2009) · Journal of Innate Immunity · doi:10.1159/000163037 · Cited by 328
Kuballa, P., Huett, A., Rioux, J. D., Daly, M. J., & Xavier, R. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003391 · Cited by 328
Nod2 is essential for temporal development of intestinal microbial communities
Rehman, A., Sina, C., Gavrilova, O., Häsler, R., Ott, S., Baines, J. F., Schreiber, S., & Rosenstiel, P. (2011) · Gut · doi:10.1136/gut.2010.216259 · Cited by 316
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90638-s · Cited by 314
Postsecretory Processing Generates Multiple Cathelicidins for Enhanced Topical Antimicrobial Defense
Murakami, M., Lopez-Garcia, B., Braff, M., Dorschner, R. A., & Gallo, R. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3070 · Cited by 308
Mucins and inflammatory bowel disease
Shirazi, T. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.898.473 · Cited by 307
Secreted enteric antimicrobial activity localises to the mucus surface layer
Meyer-Hoffert, U., Hornef, M. W., Henriques-Normark, B., Axelsson, L.-G., Midtvedt, T., Pütsep, K., & Andersson, M. (2008) · Gut · doi:10.1136/gut.2007.141481 · Cited by 304
Adherent-invasive Escherichia coli in inflammatory bowel disease
Rolhion, N., & Darfeuille-Michaud, A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20176 · Cited by 298
Mallow, E. B., Harris, A., Salzman, N., Russell, J. P., DeBerardinis, R. J., Ruchelli, E., & Bevins, C. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4038 · Cited by 296
Wehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., Schroeder, J. M., & Stange, E. F. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00001 · Cited by 295
The NLRP3 inflammasome: Contributions to intestinal homeostasis
Zaki, M. H., Lamkanfi, M., & Kanneganti, T.-D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.002 · Cited by 290
Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis
Gersemann, M., Becker, S., Kübler, I., Koslowski, M., Wang, G., Herrlinger, K. R., Griger, J., Fritz, P., Fellermann, K., Schwab, M., et al. (2009) · Differentiation · doi:10.1016/j.diff.2008.09.008 · Cited by 288
The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-4
Wehkamp, J., Wang, G., Kübler, I., Nuding, S., Gregorieff, A., Schnabel, A., Kays, R. J., Fellermann, K., Burk, O., Schwab, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3109 · Cited by 286
Holmén Larsson, J. M., Karlsson, H., Sjövall, H., & Hansson, G. C. (2009) · Glycobiology · doi:10.1093/glycob/cwp048 · Cited by 281
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
Hering, N. A., Fromm, M., & Schulzke, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224568 · Cited by 275
Hazlett, L., & Wu, M. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1022-4 · Cited by 270
Clustering of increased small intestinal permeability in families with Crohn's disease
Peeters, M., Geypens, B., Claus, D., Nevens, H., Ghoos, Y., Verbeke, G., Baert, F., Vermeire, S., Vlietinck, R., & Rutgeerts, P. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70174-4 · Cited by 261
Antimicrobial peptides important in innate immunity
Cederlund, A., Gudmundsson, G. H., & Agerberth, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08302.x · Cited by 256
Johansson, M. E. V., Thomsson, K. A., & Hansson, G. C. (2009) · Journal of Proteome Research · doi:10.1021/pr9002504 · Cited by 237
Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract
Moran, A. P., Gupta, A., & Joshi, L. (2011) · Gut · doi:10.1136/gut.2010.212704 · Cited by 236
YOSHIO, H., TOLLIN, M., GUDMUNDSSON, G. H., LAGERCRANTZ, H., J??RNVALL, H., MARCHINI, A., & AGERBERTH, B. (2003) · Pediatric Research · doi:10.1203/00006450-200302000-00003 · Cited by 233
Intestinal permeability in children with Crohn's disease and coeliac disease.
Pearson, A. D., Eastham, E. J., Laker, M. F., Craft, A. W., & Nelson, R. (1982) · BMJ · doi:10.1136/bmj.285.6334.20 · Cited by 225
Zhao, F., Edwards, R., Dizon, D., Afrasiabi, K., Mastroianni, J. R., Geyfman, M., Ouellette, A. J., Andersen, B., & Lipkin, S. M. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2009.12.008 · Cited by 221
Identification of Epithelial Gaps in Human Small and Large Intestine by Confocal Endomicroscopy
Kiesslich, R., Goetz, M., Angus, E. M., Hu, Q., Guan, Y., Potten, C., Allen, T., Neurath, M. F., Shroyer, N. F., Montrose, M. H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.011 · Cited by 217
Auvynet, C., & Rosenstein, Y. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07360.x · Cited by 212
Epithelial barrier: an interface for the cross‐communication between gut flora and immune system
Goto, Y., & Kiyono, H. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01078.x · Cited by 212
FAHLGREN, A., HAMMARSTRÖM, S., DANIELSSON, Å., & HAMMARSTRÖM, M.-L. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02035.x · Cited by 209
Müller, C. A., Autenrieth, I. B., & Peschel, A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5034-2 · Cited by 207
Söderholm, J. D., Olaison, G., Lindberg, E., Hannestad, U., Vindels, A., Tysk, C., Järnerot, G., & Sjödahl, R. (1999) · Gut · doi:10.1136/gut.44.1.96 · Cited by 206
The MUC2 gene product: a human intestinal mucin
Allen, A., Hutton, D. A., & Pearson, J. P. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00028-4 · Cited by 205
The Role of Microbes in Crohn's Disease
Eckburg, P. B., & Relman, D. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510385 · Cited by 205
Braun, A., Treede, I., Gotthardt, D., Tietje, A., Zahn, A., Ruhwald, R., Schoenfeld, U., Welsch, T., Kienle, P., Erben, G., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20993 · Cited by 201
Wehkamp, J., Fellermann, K., Herrlinger, K. R., Baxmann, S., Schmidt, K., Schwind, B., Duchrow, M., Wohlschläger, C., Feller, A. C., & Stange, E. F. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200207000-00006 · Cited by 201
Peyrin-Biroulet, L., Beisner, J., Wang, G., Nuding, S., Oommen, S. T., Kelly, D., Parmentier-Decrucq, E., Dessein, R., Merour, E., Chavatte, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905745107 · Cited by 199
Intestinal epithelial cells in inflammatory bowel diseases
Roda, G., Sartini, A., Zambon, E., Calafiore, A., Marocchi, M., Caponi, A., Belluzzi, A., & Roda, E. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i34.4264 · Cited by 195
Ehehalt, R., Wagenblast, J., Erben, G., Lehmann, W., Hinz, U., Merle, U., & Stremmel, W. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410006233 · Cited by 194
Abnormal Intestinal Permeability Predicts Relapse in Inactive Crohn Disease
I. D. R. Arnott, K. K. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750056637 · Cited by 182
Paneth cell α-defensins in enteric innate immunity
Ouellette, A. J. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0714-6 · Cited by 180
Moehle, C., Ackermann, N., Langmann, T., Aslanidis, C., Kel, A., Kel-Margoulis, O., Schmitz-Madry, A., Zahn, A., Stremmel, W., & Schmitz, G. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0100-2 · Cited by 180
Quantitative Analysis of MUC2 Synthesis in Ulcerative Colitis
Tytgat, K. M. A. J., van der Wal, J.-W. G., Einerhand, A. W. C., Büller, H. A., & Dekker, J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1039 · Cited by 176
Potential Roles of Histones in Host Defense as Antimicrobial Agents
Kawasaki, H., & Iwamuro, S. (2008) · Infectious Disorders - Drug Targets · doi:10.2174/1871526510808030195 · Cited by 176
Mucosal flora in Crohn's disease and ulcerative colitis - an overview.
Swidsinski, A. V., Loening-Baucke, V. A., & Herber, A. (2009) · PubMed · Cited by 174
Glycoprotein Composition of Colonic Mucosa
Podolsky, D. K., & Isselbacher, K. J. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80055-4 · Cited by 168
Schoultz, I., Verma, D., Halfvarsson, J., Törkvist, L., Fredrikson, M., Sjöqvist, U., Lördal, M., Tysk, C., Lerm, M., Söderkvist, P., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.29 · Cited by 166
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
Schauber, J., Rieger, D., Weiler, F., Wehkamp, J., Eck, M., Fellermann, K., Scheppach, W., Gallo, R. L., & Stange, E. F. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200606000-00007 · Cited by 165
Processing of Seminal Plasma hCAP-18 to ALL-38 by Gastricsin
Sørensen, O. E., Gram, L., Johnsen, A. H., Andersson, E., Bangsbøll, S., Tjabringa, G. S., Hiemstra, P. S., Malm, J., Egesten, A., & Borregaard, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301608200 · Cited by 164
Increased Enterocyte Apoptosis in Inflamed Areas of Crohn's Disease
Di Sabatino, A., Ciccocioppo, R., Luinetti, O., Ricevuti, L., Morera, R., Cifone, M. G., Solcia, E., & Corazza, G. R. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6802-z · Cited by 164
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease
Wehkamp, J., Schmid, M., Fellermann, K., & Stange, E. F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904543 · Cited by 164
Reduced mucosal antimicrobial activity in Crohn’s disease of the colon
Nuding, S., Fellermann, K., Wehkamp, J., & Stange, E. F. (2007) · Gut · doi:10.1136/gut.2006.118646 · Cited by 163
Brand, S., Konrad, A., Crispin, A., Göke, B., Lohse, P., & Ochsenkühn, T. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000168372.94907.d2 · Cited by 163
Wehkamp, J., Koslowski, M. J., Wang, G., & Stange, E. F. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.48 · Cited by 150
Rolhion, N., Barnich, N., Bringer, M.-A., Glasser, A.-L., Ranc, J., Hébuterne, X., Hofman, P. M., & Darfeuille–Michaud, A. (2010) · Gut · doi:10.1136/gut.2010.207456 · Cited by 149
The role of the multifunctional peptide LL-37 in host defense
Kai-Larsen, Y., & Agerberth, B. (2008) · Frontiers in bioscience · doi:10.2741/2964 · Cited by 146
Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease
Zheng, W., Rosenstiel, P. C., Huse, K., Sina, C., Valentonyte, R., Mah, N., Zeitlmann, L., Grosse, J., Ruf, N., Nürnberg, P., et al. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364263 · Cited by 145
Koslowski, M. J., Kübler, I., Chamaillard, M., Schaeffeler, E., Reinisch, W., Wang, G., Beisner, J., Teml, A., Peyrin‐Biroulet, L., Winter, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004496 · Cited by 143
Wehkamp, J., & Stange, E. F. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.05.010 · Cited by 143
Antimicrobial peptides in the first line defence of human colon mucosa
Tollin, M., Bergman, P., Svenberg, T., Jörnvall, H., Gudmundsson, G. H., & Agerberth, B. (2003) · Peptides · doi:10.1016/s0196-9781(03)00114-1 · Cited by 141
From intestinal stem cells to inflammatory bowel diseases.
Gersemann, M., Stange, E. F., & Wehkamp, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i27.3198 · Cited by 140
Innate immune signaling in defense against intestinal microbes
Kinnebrew, M. A., & Pamer, E. G. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01081.x · Cited by 138
Human colonic mucus is a reservoir for antimicrobial peptides
Antoni, L., Nuding, S., Weller, D., Gersemann, M., Ott, G., Wehkamp, J., & Stange, E. F. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.05.006 · Cited by 132
Self-citationReview: Human antimicrobial proteins — effectors of innate immunity
Harder, J., Gläser, R., & Schröder, J. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907088275 · Cited by 131
FAHLGREN, A., Hammarström, S., Danielsson, A., & Hammarström, M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02543.x · Cited by 131
Raouf, A. H., Tsai, H. H., Parker, N., Hoffman, J., Walker, R. J., & Rhodes, J. M. (1992) · Clinical Science · doi:10.1042/cs0830623 · Cited by 125
Schmid, M., Fellermann, K., Fritz, P., Wiedow, O., Stange, E. F., & Wehkamp, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906581 · Cited by 116
Innate immune defenses in the intestinal tract
Dann, S. M., & Eckmann, L. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32803cadf4 · Cited by 107
The N‐ and C‐terminal fragments of ubiquitin are important for the antimicrobial activities
Kieffer, A., Goumon, Y., Ruh, O., Chasserot‐Golaz, S., Nullans, G., Gasnier, C., Aunis, D., & Metz‐Boutigue, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0699fje · Cited by 102
Sanz, Y., & Palma, G. D. (2009) · International Reviews of Immunology · doi:10.3109/08830180903215613 · Cited by 102
Thachil, É., Hugot, J., Arbeille, B., Paris, R., Grodet, A., Peuchmaur, M. M., Codogno, P., Barreau, F., Ogier‐Denis, É., Berrebi, D. D., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.031 · Cited by 101
Insights into IBD pathogenesis
Shih, D. Q., & Targan, S. R. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0072-9 · Cited by 101
Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3
Kyo, K., Parkes, M., Takei, Y., Nishimori, H., Vyas, P., Satsangi, J., Simmons, J., Nagawa, H., Baba, S., Jewell, D., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.307 · Cited by 101
Roadblocks in the gut: barriers to enteric infection
Gill, N., Wlodarska, M., & Finlay, B. B. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01578.x · Cited by 100
Yacyshyn, B., & Meddings, J. B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90017-9 · Cited by 100
Colonic mucins in ulcerative colitis: evidence for loss of sulfation
Corfield, A. P., Myerscough, N., Bradfield, N., Corfield, C. D. A., Gough, M., Clamp, J. R., Durdey, P., Warren, B. F., Bartolo, D. C. C., King, K. R., et al. (1996) · Glycoconjugate Journal · doi:10.1007/bf00702345 · Cited by 100
Colonic glycoproteins in monozygotic twins with inflammatory bowel disease
Tysk, C., Riedesel, H., Lindberg, E., Panzini, B., Podolsky, D. K., & Järnerot, G. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90211-3 · Cited by 98
Increased intestinal permeability in patients with inflammatory bowel disease.
Welcker, K., Martín, A., Kölle, P., Siebeck, M., & Gross, M. (2004) · PubMed · Cited by 95
Perspectives on Mucus Properties and Formation--Lessons from the Biochemical World
Ambort, D., Johansson, M., Gustafsson, J. K., Ermund, A., & Hansson, G. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014159 · Cited by 93
The antimicrobial peptide cathelicidin interacts with airway mucus
Felgentreff, K., Beißwenger, C., Griese, M., Gulder, T., Bringmann, G., & Bals, R. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.018 · Cited by 90
Toll-Like Receptors Promote Mutually Beneficial Commensal-Host Interactions
Kubinak, J. L., & Round, J. L. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002785 · Cited by 88
Riis, L. B., Vind, I., Vermeire, S., Wolters, F. J., Katsanos, K., Politi, P., Freitas, J., Mouzas, I., O'Morain, C. A., Ruiz-Ochoa, V., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20047 · Cited by 86
Study of the Carbohydrate Content of Mucus Glycoproteins from Normal and Diseased Colons
Clamp, J. R., Fraser, G., & Read, A. E. (1981) · Clinical Science · doi:10.1042/cs0610229 · Cited by 80
Bucki, R., Namiot, D. B., Namiot, Z., Savage, P. B., & Janmey, P. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn176 · Cited by 77
Mucosal Protection by Phosphatidylcholine
Stremmel, W., Ehehalt, R., Staffer, S., Stoffels, S., Mohr, A., Karner, M., & Braun, A. (2012) · Digestive Diseases · doi:10.1159/000342729 · Cited by 75
Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease
Breslin, N. P., Nash, C., Hilsden, R. J., Hershfield, N. B., Price, L. M., Meddings, J. B., & Sutherland, L. R. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04684.x · Cited by 73
The Role of Infection in Inflammatory Bowel Disease
Brender-Gotlieb, N., & Lidar, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63269-2.00057-x · Cited by 70
51CrEDTA colonic permeability and therapy response in patients with ulcerative colitis
Arslan, G., Atasever, T., Cindoruk, M., & Yıldırım, İ. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200109000-00009 · Cited by 64
Antimicrobial polypeptides of the human colonic epithelium
Howell, S. J., Wilk, D. J., Yadav, S. P., & Bevins, C. L. (2003) · Peptides · doi:10.1016/j.peptides.2003.07.028 · Cited by 62
Innate antimicrobial host defense in small intestinal Crohn's disease
Koslowski, M. J., Beisner, J., Stange, E. F., & Wehkamp, J. (2009) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.011 · Cited by 60
Lewis, G. J., Massey, D. C. O., Zhang, H., Bredin, F., Tremelling, M., Lee, J. C., Berzuini, C., & Parkes, M. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21499 · Cited by 60
Crohn’s disease-Defect in innate defence
Gersemann, M., Wehkamp, J., Fellermann, K., & Stange, E. F. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5499 · Cited by 59
Koslowski, M. J., Teltschik, Z., Beisner, J., Schaeffeler, E., Wang, G., Kübler, I., Gersemann, M., Cooney, R. M., Jewell, D. P., Reinisch, W., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002523 · Cited by 58
Sípos, F., Molnar, B. A., Zágoni, T., Berczi, L., & Tulassay, Z. (2005) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-0831-5 · Cited by 58
Bodger, K. (2006) · Gut · doi:10.1136/gut.2005.086413 · Cited by 55
Rigoli, L. C., Romano, C., Caruso, R. A., Presti, M. A. L., Bella, C. D., Procopio, V., Giudice, G. L., Amorini, M., Costantino, G., Sergi, M. D., et al. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4454 · Cited by 49
Raouf, A., Parker, N., Iddon, D., Ryder, S. D., Langdon-Brown, B., Milton, J. D., Walker, R. J., & Rhodes, J. M. (1991) · Gut · doi:10.1136/gut.32.10.1139 · Cited by 48
The Interaction of Large Bowel Microflora with the Colonic Mucus Barrier
Pearson, J. P., & Brownlee, I. A. (2010) · International Journal of Inflammation · doi:10.4061/2010/321426 · Cited by 46
Molecular basis of canonical and bactericidal autophagy
Noda, T., & Yoshimori, T. (2009) · International Immunology · doi:10.1093/intimm/dxp088 · Cited by 43
Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules
Metz-Boutigue, M.-H., Shooshtarizadeh, P., Prevost, G., Haikel, Y., & Chich, J.-F. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790963823 · Cited by 42
Prodefensins are matrix proteins of specific granules in human neutrophils
Faurschou, M., Kamp, S., Cowland, J. B., Udby, L., Johnsen, A. H., Calafat, J., Winther, H., & Borregaard, N. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1104688 · Cited by 38
Baumgart, D. C., Büning, C., Geerdts, L., Schmidt, H. H.-J., Büttner, J., Fiedler, T., Gentz, E., Molnár, T., Nagy, F., Lonovics, J., et al. (2007) · Digestion · doi:10.1159/000112646 · Cited by 29
Mucins and Immune Reactions to Mucins in Ulcerative Colitis
Hayashi, T., Ishida, T., Motoya, S., et al. (2001) · Digestion · doi:10.1159/000051907 · Cited by 27
Cited by
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110
“…characterized by overt inflammation, is also associated with intestinal barrier dysfunction (Laukoetter et al., 2008; Marchiando et al., 2010; Antoni et al., 2014) increased intestinal permeability (Gerova et al., 2011) immune dysregulation and an altered gut microbiota (Sartor and…”
BackgroundMichielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709
“Indeed, the diminished Paneth cell antimicrobial function might be a primary pathogenic factor in CD, particularly ileal CD [24, 43, 52, 53], while the increased secretion of defensins in UC may be a physiological response to mucosal damage.”
BackgroundInfluentialAdherent-invasive Escherichia coli in inflammatory bowel disease
Palmela, C., Chevarin, C., Xu, Z., Torres, J., Sevrin, G., Hirten, R., Barnich, N., Ng, S. C., & Colombel, J.-F. (2018) · Gut · doi:10.1136/gutjnl-2017-314903 · Cited by 535
Hua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00524 · Cited by 527
Metadata
- Authors
- Antoni, L.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 5
- Pages
- 1165
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2092744572
- Cited by
- 413
- References
- 166
- FWCI
- 13.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.